Meta-analysis of negative-pressure wound therapy for closed surgical incisions by Hyldig, N et al.
Syddansk Universitet
Meta-analysis of negative-pressure wound therapy for closed surgical incisions
Hyldig, Nana; Birke-Sorensen, H; Kruse, Marie; Vinter, Christina Anne; Jørgensen, Jan
Stener; Sørensen, Jens Ahm; Mogensen, Ole; Lamont, Ronald Francis; Bille, Camilla
Published in:
British Journal of Surgery
DOI:
10.1002/bjs.10084
Publication date:
2016
Document version
Publisher's PDF, also known as Version of record
Document license
CC BY-NC
Citation for pulished version (APA):
Hyldig, N., Birke-Sorensen, H., Kruse, M., Vinter, C., Joergensen, J. S., Sorensen, J. A., ... Bille, C. (2016).
Meta-analysis of negative-pressure wound therapy for closed surgical incisions. British Journal of Surgery,
103(5), 477-486. DOI: 10.1002/bjs.10084
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 09. Sep. 2018
Systematic review
Meta-analysis of negative-pressure wound therapy for closed
surgical incisions
N. Hyldig1,2, H. Birke-Sorensen4, M. Kruse3, C. Vinter2, J. S. Joergensen2, J. A. Sorensen1,
O. Mogensen2, R. F. Lamont2,5 and C. Bille1
1Department of Plastic Surgery, Odense University Hospital, University of Southern Denmark, Institute of Clinical Research, Research Unit of Plastic
Surgery, 2Department of Gynaecology and Obstetrics, Odense University Hospital, University of Southern Denmark, Institute of Clinical Research,
Research Unit of Gynaecology and Obstetrics, and 3Centre for Health Economics Research (COHERE), University of Southern Denmark, Odense, and
4Institute of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark, and 5Division of Surgery, University College London, Northwick Park
Institute of Medical Research Campus, London, UK
Correspondence to:Ms N. Hyldig, Kloevervaenget 10, 10th Floor, Odense University Hospital, 5000Odense, Denmark (e-mail: nana.hyldig@rsyd.dk)
Background: Postoperative wound complications are common following surgical procedures. Negative-
pressure wound therapy (NPWT) is well recognized for the management of open wounds and has been
applied recently to closed surgical incisions. The evidence base to support this intervention is limited.
The aim of this study was to assess whether NPWT reduces postoperative wound complications when
applied to closed surgical incisions.
Methods: This was a systematic review and meta-analysis of randomized clinical trials of NPWT
compared with standard postoperative dressings on closed surgical incisions.
Results: Ten studies met the inclusion criteria, reporting on 1311 incisions in 1089 patients. NPWTwas
associated with a significant reduction in wound infection (relative risk (RR) 0⋅54, 95 per cent c.i. 0⋅33 to
0⋅89) and seroma formation (RR 0⋅48, 0⋅27 to 0⋅84) compared with standard care. The reduction in wound
dehiscence was not significant. The numbers needed to treat were three (seroma), 17 (dehiscence) and
25 (infection). Methodological heterogeneity across studies led to downgrading of the quality of evidence
to moderate for infection and seroma, and low for dehiscence.
Conclusion: Compared with standard postoperative dressings, NPWT significantly reduced the rate of
wound infection and seromawhen applied to closed surgical wounds.Heterogeneity between the included
studies means that no general recommendations can be made yet.
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Spain, May 2013, and to the Second Nordic Congress on Obesity in Gynaecology and Obstetrics,
Middelfart, Denmark, August 2015
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Introduction
Postoperative wound complications, such as infection,
dehiscence, and formation of haematoma or seroma, are
common complications of surgical procedures1,2, particu-
larly among patients with risk factors such as obesity and
diabetes3–5. Postoperative wound complications may lead
to increased healthcare costs due to prolonged inpatient
stay, repeat surgery and the need for increased follow-up6,7.
Wound complications may also delay recovery, increase
discomfort and reduce quality of life8,9.
Negative-pressure wound therapy (NPWT) is usually
used for the treatment of open wounds. The wound is
filled with a gauze or foam and sealed with an adhesive
film dressing. The dressing is then connected to a vacuum
device via a drain or port. The device ensures that nega-
tive pressure is transmitted to the wound bed and removes
wound fluid10. The mechanisms of action include a char-
acteristic pattern of blood flow around the wound, reduc-
tion in tissue oedema and stimulation of granulation tissue
formation10–12. In recent years, the indication for NPWT
has been extended to include treatment of closed surgical
incisions (incisional NPWT, iNPWT). Some of the first
studies were case series13,14 and observational studies15,16
using one of the existingNPWTdevices (VAC®; KCI, San
Antonio, Texas, USA) designed for open wounds17,18. Two
simplified NPWT devices became commercially available
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Fig. 1 A negative-pressure wound therapy dressing in situ
in 2010 (Prevena™; KCI) and 2011 (PICO™; Smith &
Nephew, Hull, UK). These NPWT devices consist of
a single-use battery-powered negative-pressure therapy
device, an easy-to-place dressing, and either a very small
and easily portable canister, or no canister at all. In the
latter case, the liquid is removed by evaporation through
a semipermeable dressing. The mechanisms of action of
this closed incision management have been supported by
biomechanical studies: increased blood flow14,19; decreased
lateral and shear stress at the suture lines with decreased
risk of wound dehiscence20; and increased lymph clearance
with reduced formation of haematoma/seroma21 (Fig. 1).
This systematic review investigated whether NPWT
reduces the risk of wound complications such as wound
infection, wound dehiscence and seroma when used on
closed surgical incisions. It updates previous reviews22,23,
and includes data from new and unpublished trials.
The quality of evidence of each outcome was evaluated
thoroughly. Finally, the study applies assimilated data
and includes a meta-analysis, with the aim of providing
robust evidence of the effect of NPWT on closed surgical
incisions.
Watch three of the authors in a live video discussion of
the results from the systematic review and the mode of
action of iNPWT here.
Methods
The systematic review was conducted using well recog-
nized methodology24 and reported in accordance with the
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) statement25.
Eligibility criteria
Only randomized clinical trials (RCTs) comparing
iNPWT with standard postoperative dressings were
included. Studies that used NPWT devices designed for
open wounds and surgical incisions, as well as studies that
used home-made NPWT devices, were accepted for inclu-
sion. The standard dressings were any dressing used for
surgical incisions, such as a sterile gauze dressing. The out-
comes were wound complications, with wound infection,
wound dehiscence and seroma as primary outcomes. No
restrictions were made according to authors’ definitions of
outcome. Studies investigating the effect of iNPWT on
other kinds of wound were excluded from the review.
Search strategy
The search strategy used the medical subject headings
(MeSH) terms and free text words: ‘incisions’, ‘surgical
procedures’ and ‘negative pressure wound therapy’
(Appendix S1, supporting information). The search strategy
from the Cochrane Review22 was used when searching
the Cochrane Library. In addition, the register Clinical-
Trials.gov was searched and the authors contacted the
manufacturers (KCI and Smith & Nephew) to identify
ongoing trials. Finally, reference lists of identified studies,
previously published systematic reviews and review articles
were explored for additional references. There was no
language restriction. To maintain a high sensitivity in the
search strategy, no study design filters were used. One
author searched the databases, assisted by a research librar-
ian. The last literature search was performed on 1 August
2015.
Study selection and collection process
Two screening authors independently reviewed studies
with full-text assessment. From each included study, data
were extracted on: the number and characteristics of the
participants (including surgical procedure, and inclusion
and exclusion criteria); the type of intervention (including
type of NPWT device, type of dressing used in the con-
trol group for comparison, and duration of treatment in the
intervention and control groups); the outcome measures,
with specific definitions as reported in each study (includ-
ing formation of haematoma or seroma, wound infection,
dehiscence and other outcomes). If the information was
inadequate, the corresponding authors were contacted for
additional information.
Risk of bias in individual studies
To determine the risk of bias, two authors independently
assessed the adequacy of sequence generation, concealment
of allocation, blinding of outcome assessor, completeness
of outcome data, and risk of selective outcomes and other
© 2016 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2016; 103: 477–486
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Potentially relevant citations identified
and screened for retrieval
n = 872
Citations retrieved for more detailed
evaluation
n = 83
Irrelevant citations excluded
after screening all titles and abstracts
n = 789
RCTs included in meta-analysis
n = 10
RCTs with usable information,
by outcome
n = 10
Citations excluded n = 79
 Review/overview n = 14
 Prospective, not randomized, trial n = 5
 Pilot study n = 6
 Retrospective study n = 15
 Case report n = 14
 Cost analysis n = 5
 Technical report n = 8
 Conference abstract n = 9
 Unpublished studies n = 3
RCTs withdrawn, by outcome n = 0
Unpublished studies n = 6
Fig. 2 PRISMA diagram showing the selection of articles. RCT, randomized clinical trial
bias using the Cochrane Collaboration tool26. Each item
was deemed adequate, unclear or inadequate. Any disagree-
ments between reviewers were resolved by consensus.
Synthesis of results
Data from each of the studies were organized in 2× 2
contingency tables and used to calculate the relative risk
(RR) for wound complications with associated 95 per cent
c.i. The mean difference was used to summarize continu-
ous data.
The meta-analyses applied the random-effects model
of DerSimonian and Laird27. The random-effects model
was chosen because the studies assessed different kinds of
surgical incision and therefore clinical heterogeneity was
expected. Accordingly, the studies were treated as random
samples, assuming that the true effect varied between stud-
ies. Study design effect and unit of analysis was taken into
consideration to calculate the standard error based on the
original study design (a detailed explanation can be found in
Appendix S1, supporting information)26,28. Statistical het-
erogeneity was examined as between-study variation and
tested using the Cochran Q test. Heterogeneity was quan-
tified with the I2 measuring the proportion of variation
(inconsistency) in the combined estimates29. An I2 value of
0 per cent indicates no inconsistency between the results of
individual trials, and an I2 value of 100 per cent indicates
maximal inconsistency. Number needed to treat (NNT)
to avoid a particular adverse outcome was calculated as
1/(ACR× (1−RR)), where ACR is the assumed control
risk26. All analyses were conducted in STATA® version
13.1 (StataCorp LP, College Station, Texas, USA). If a
study was evaluated as having a high risk of bias that might
influence the pooled estimates of the outcome of interest,
a subgroup analysis was conducted, excluding that study.
The quality of evidence for each outcome was rated using
the Grading of Recommendations Assessment, Develop-
ment, and Evaluation (GRADE) system30. The evidence
was classified as: high quality (the authors are very confi-
dent that the true effect lies close to that of the estimate of
the effect); moderate quality (the authors are moderately
confident in the effect estimate); low quality (the authors’
confidence in the effect estimate is limited); or very low
quality (the authors have very little confidence in the effect
estimate)30,31. The small study bias was assessed visually by
examining the symmetry of funnel plots, and statistically as
described by Egger et al.32.
Results
Study selection
The search of MEDLINE, Embase, the Cumulative Index
to Nursing and Allied Health Literature (CINAHL) and
the Cochrane Library provided a total of 1052 citations.
After removal of duplicates, 872 remained. Eighty-three
full-text papers were retrieved for inspection, of which
© 2016 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2016; 103: 477–486
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Table 1 Characteristics of included studies
Reference Country
No. of
incisions
Type of
surgery Treatment*
Inclusion and
exclusion criteria Outcome measures† Follow-up
Howell et al.33 USA 60 Total knee
arthroplasty
VAC® versus sterile gauze
(dressing not described)
(all wounds were
assessed after 48 h)
Inclusion: BMI≥ 30 kg/m2
and enoxaparin sodium for
DVT
Primary: days to a dry
wound (no drainage on
gauze for 24 h)
12months
Exclusion: revision total knee
replacement, previous
knee surgery and
documented diabetes
Secondary: total wound
drainage, no. of gauze
dressings applied to the
wound, duration of
hospital stay, incidence
of infection, readmission
Pachowsky et al.34 Germany 19 Total hip arthroplasty Prevena™ versus ‘a dry
wound coverage’
(dressing not described)
(5 days versus n.s.)
n.s. Primary: seroma
(ultrasound imaging of
the wound was used to
show a seroma)
10 days
Grauhan et al.35 Germany 150 Median sternotomy Prevena™ versus
conventional wound
dressings (dressing not
described) (6–7 days
versus 1–2days)
Inclusion: BMI≥ 30 kg/m2,
and absence of
preoperative signs of
inflammation
Exclusion: immunological
disease,
immunosuppressive
therapy, skin disease
Primary: wound infection
(defined according to
US Centers for Disease
Control and Prevention
criteria)
90 days
Secondary: dehiscence of
skin or sternum
Masden et al.36 USA 81 Primary or delayed
primary closure of
lower extremity or
abdominal wounds
VAC® versus standard dry
sterile dressing
(Mepitel®) and a
bacteriostatic single
silver layer (Acticoat™)
(all wounds assessed on
day 3)
Inclusion: scheduled to
undergo primary or
delayed primary closure
Primary: wound infection,
wound dehiscence
(evaluated by a member
of the research team,
blinded to
randomization groups)
Average of
113days
Exclusion: patients allergic to
tape or who could not
tolerate NPWT; patients
with lower-extremity
amputations distal to
forefoot
Secondary: reoperation,
duration of hospital stay
Stannard et al.37 USA 263 High-risk lower
extremity fractures
(tibial plateau, pilon,
calcaneus)
VAC® versus standard
postoperative dressing
(dressing not described)
(all wounds assessed on
day 2)
Inclusion: presence of a
high-energy tibial plateau,
pilon or calcaneus
fractures
Primary: wound infection
(defined with a
combination of clinical
signs and symptoms
and laboratory data),
wound dehiscence
(defined as any
separation of the
incision that required
wound care or
reoperation)
n.s.
Exclusion: non-operative or
open fractures, receiving
definitive surgery more
than 16days after injury,
pregnant women and
patients with low-energy
fractures
Pauser et al.38 Germany 21 Hemiathroplasty Prevena™ versus ‘a dry
wound coverage’
(dressing not described)
(5 days versus n.s.)
n.s. Primary: seroma
(ultrasound imaging of
the wound was used to
show a seroma)
10 days
Nordmeyer et al.39 Germany 20 Spinal fracture PICO™ versus ‘a dry
wound coverage’
(dressing not described)
(5 days versus n.s.)
n.s. Primary: seroma
(ultrasound imaging of
the wound was used to
show a seroma)
10 days
B. D. Crist et al.
(personal
communication)
USA 90 Pelvic, acetabular and
hip fractures
VAC® versus a standard
gauze (dressing not
described) (all wounds
assessed on day 2)
Inclusion: age 18 years or
older, scheduled for
surgical repair of pelvic
and/or acetabular fracture,
and subject/guardian able
to provide informed
consent
Primary: deep wound
infection (‘Deep
infection was one that
went to the OR’)
Secondary: wound
drainage, duration of
hospital stay, dressing
supply costs, nursing
time cost for dressing
changes
12months
Exclusion: pregnancy, injury
treated percutaneously
without open surgery
© 2016 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2016; 103: 477–486
on behalf of BJS Society Ltd.
Negative-pressure wound therapy for closed surgical incisions 481
Table 1 Continued
Reference Country
No. of
incisions
Type of
surgery Treatment
Inclusion and
exclusion criteria Outcome measures Follow-up
S. Karlakki et al.
(personal
communication)
UK 209 Hip and knee
replacement
PICO™ versus
Mepore® or
Tegaderm™+Pad
(3M) (7 days versus
2days)
Exclusion: known allergies
to dressings, and those
on warfarin
Primary: exudate from the
surgical wound
(predefined grading of
wound exudate)
6weeks
Secondary: wound
complications,
readmissions, no. of
dressing changes,
overall
cost-effectiveness
R. Galiano et al.
(personal
communication)
USA, South
Africa, France
and the
Netherlands
398 Bilateral breast
reduction
PICO™ versus
Steri-Strip™ (7days
versus 7days)
n.s. Primary: delayed healing,
dehiscence, wound
infection (predefined
description of primary
outcome not stated)
21 days
Secondary: scar quality 90 days
Text in parentheses indicates *duration of treatment before first dressing change and †predefined description of primary outcome. Mepitel™ (Mölnlycke
Health Care, Gothenburg, Sweden); Acticoat™ (Smith & Nephew, Hull, UK); Mepore® (Mölnlycke Health Care); Tegaderm™ (3M, St Paul,
Minnesota, USA); Steri-Strip™ (3M). BMI, body mass index; DVT, deep vein thrombosis; n.s., not stated; NPWT, negative-pressure wound therapy;
OR, operating room.
seven were RCTs33–39. A further six unpublished stud-
ies were identified through contact with manufacturers
and by searching ClinicalTrials.gov. The authors of all
six unpublished studies were contacted; three responded
with copies of submitted manuscripts (B. D. Crist et al.
and S. Karlakki et al., personal communication) or posters
(R. Galiano et al., personal communication). One study
(V. Tanaydin, personal communication) was not ready for
publication. A total of ten studies were included in the
review (Fig. 2).
Study characteristics
Four studies33,36,37, including that of B. D. Crist et al. (per-
sonal communication), used an NPWT device (VAC®)
and six34,35,38,39, including those of S. Karlakki et al. and
R. Galiano et al. (personal communication), employed
an iNPWT device (Prevena™/PICO™). No studies of
home-made NPWT devices or studies comparing two
different NPWT devices were found. One of the included
studies was not reported as an RCT35. However, it was
reported as a prospective trial describing a kind of ran-
domization, and therefore is classified here as an RCT.
This particular study was also categorized as an RCT in
another review40. Hence, all ten studies selected for this
review were rated as RCTs of NPWT versus standard
postoperative dressings on closed surgical incisions. The
patients were all at high risk of wound complications,
due to either the surgical procedure or co-morbidities.
One study36 included both primary and delayed primary
sutured incisions. In two studies33,37 some of the patients
had more than one wound treated with the interven-
tion. Another study randomized by body part, treating
each patient with both iNPWT and standard dressing
(R. Galiano et al., personal communication). One study33
was stopped prematurely because of adverse reactions to
iNPWT. Table 1 displays the characteristics of the included
studies.
Risk of bias within studies
The assessment of risk of bias within studies is shown
in Table S1 (supporting information). Generally, the
studies were reported incompletely (Fig. S1, support-
ing information). To obtain the missing information,
the corresponding authors of the seven published
papers were contacted. One study37 provided the infor-
mation requested. One author36 did not respond to
the request, but had corresponded with the authors
of the Cochrane review22. Accordingly, for this spe-
cific trial, the information from the Cochrane review
was used.
The included trials were of moderate methodological
quality. In general, randomization and allocation conceal-
ment were not described adequately. Blinding of outcome
assessment was described adequately in two studies36,37.
Three studies35,36, including that of B. D. Crist et al. (per-
sonal communication), did not describe loss to follow-up
properly. There did not appear to be selective reporting
bias. Finally, all studies, except one35, were either spon-
sored or had at least one consultant of a manufacturer as
co-author.
© 2016 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2016; 103: 477–486
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Table 2 Summary of findings: incisional negative-pressure wound therapy versus standard dressing for prevention of postoperative
wound complications
Anticipated absolute effect (per 100)*
Outcome Risk with standard dressing Risk with iNPWT Relative risk No. of incisions Quality of evidence† NNT
Wound infection 9 5 (3, 8) 0⋅54 (0⋅33, 0⋅89) 1251 (7 RCTs) Moderate‡ 25 (17, 93)
Wound dehiscence 20 14 (9, 21) 0⋅69 (0⋅47, 1⋅01) 892 (4 RCTs) Low‡§ 17 (10, −500)
Seroma 85 41 (23, 71) 0⋅48 (0⋅27, 0⋅84) 40 (2 RCTs) Moderate‡¶ 3 (2, 8)
Values in parentheses are 95 per cent c.i. *The risk in the intervention group (incisional negative-pressure wound therapy, iNPWT) is based on the
assumed risk in the comparison group (standard dressing) and the relative risk of the intervention. †Evaluated using the Grading of Recommendations
Assessment, Development, and Evaluation (GRADE) system30 (see text for full details); ‡moderate risk of bias in study; §inconsistency of direction of
effect; ¶imprecision owing to small sample size. NNT, number needed to treat; RCT, randomized clinical trial.
Results of individual studies
The ten included studies recruited a total of 1089 patients
with 1311 incisions, of which 664 were treated with
iNPWT and 647 with a standard postoperative dressing.
The duration of treatment before first change of dress-
ing varied from 2 to 7 (median 5) days in the interven-
tion group and from 1 to 7 (median 2) days in the control
group (duration was not stated in 3 studies34,38,39). The
length of follow-up varied from 10 days to 1 year. Only
two studies (S. Karlakki et al. and R. Galiano et al., per-
sonal communication) recorded the time points of evalu-
ation and how the outcomes were assessed after discharge.
The reported outcome was wound infection in seven of ten
studies (1251 incisions), wound dehiscence in four stud-
ies (892 incisions) and seroma in three (60 incisions). One
study (S. Karlakki et al., personal communication; 209 inci-
sions) reported wound exudate as a primary outcome, and
another study33 (60 incisions) reported ‘days to dry wound’.
Synthesis of results
Wound infection
Wound infection was reported in seven studies33,35–37,
including the three unpublished studies. Of 634 patients
treated with iNPWT, 30 (4⋅7 per cent) developed a wound
infection, compared with 55 (8⋅9 per cent) of 617 in
the control group (RR 0⋅54, 95 per cent c.i. 0⋅33 to
0⋅89) (Table 2; Fig. S2, supporting information). Two studies
(reference 33 and B. D. Crist et al., personal communica-
tion) included only deep infections, and the meta-analysis
was therefore stratified by type of infection (overall and
deep). Overall there was some statistical heterogeneity
(I2 = 11⋅1 per cent), but when stratified by type of infec-
tion, heterogeneity was reduced to 0 per cent in both
subgroups. From the pooled data, the NNT to avoid
one wound infection was 25 (95 per cent c.i. 17 to 93)
(Table 2). The quality of evidence was downgraded to
moderate, because of variability across studies and some
methodological heterogeneity41. Two subgroup analyses
were conducted. One omitted the study of Grauhan and
colleagues35, which used alternation according to the time
of operation as this can lead to selection bias42. The
other subgroup analysis omitted the study that was stopped
prematurely33. The pooled estimate and its 95 per cent c.i.
did not change appreciably in direction or significance in
either of the subanalyses (data not shown).
Wound dehiscence
Wound dehiscence was reported in four studies that
reported on sternotomy35, extremity wounds36 or
fractures37, and breast reduction (R. Galiano et al., per-
sonal communication). Three studies35,37, including that
of R. Galiano et al. (personal communication), found that
iNPWT reduced the risk of dehiscence, whereas one
study36 found an increased risk of wound dehiscence.
Overall, dehiscence occurred in 61 (13⋅3 per cent) of 459
patients in the iNPWT group, compared with 86 (20⋅0 per
cent) of 433 with standard dressings (RR 0⋅69, 95 per cent
c.i. 0⋅47 to 1⋅01; I2 = 37⋅3 per cent). Owing to inconsis-
tency in the direction of effect on wound dehiscence and
a moderate risk of bias, the quality of evidence was down-
graded to low43. The NNT to avoid wound dehiscence
was 17; as the treatment effect was not significant, the 95
per cent c.i. became negative (10 to −500) (Table 2).
Seroma
Three studies, two on hip arthroplasty34,38 and one on
spinal fractures39, reported on seroma. The two studies
on hip arthroplasty reported on the presence or absence
of seroma. A seroma was present in eight (40 per cent)
of 20 patients in the iNPWT group compared with 17
(85 per cent) of 20 in the standard dressing group (RR
0⋅48, 95 per cent c.i. 0⋅27 to 0⋅84; I2 = 0 per cent) (Table 2
and Fig. S2, supporting information). The NNT to avoid
a seroma was 3 (95 per cent c.i. 2 to 8) (Table 2). All
three studies reported the volume of seroma measured by
ultrasonography on day 5, and two studies34,39 reported
© 2016 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2016; 103: 477–486
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the volume on day 10. The mean difference between
the two groups was −1⋅97 (95 per cent c.i. −3⋅13 to
−0⋅82) and −1⋅44 (−3⋅02 to 0⋅13)ml respectively, favour-
ing the iNPWT group (Fig. S3, supporting information).
The same research group designed and conducted all three
studies on seroma, and the studies were methodologically
homogeneous. The quality of evidence was downgraded to
moderate because of missing methodological information
resulting in moderate risk of bias, and because of the few
studies, with small sample sizes41,44.
Other wound complications
Wound exudate was reported as a primary outcome in one
study on hip and knee replacement (S. Karlakki et al., per-
sonal communication), which found that iNPWT signifi-
cantly reduced the amount of wound exudate covering 50
per cent or more of the dressing. Five (4⋅9 per cent) of
102 patients in the intervention group and 21 (19⋅6 per
cent) of 107 in the control group had exudate covering 50
per cent or more of the dressing. The difference was most
pronounced for hip replacement, and increased with risk
factors such as high body mass index (above 35 kg/m2), no
drain, and wound closure with sutures. ‘Days to dry wound’
was reported in one study33 focusing on total knee arthro-
plasty. There was no significant difference in the days to dry
wound between patients who had NPWT (4⋅3 (95 per cent
c.i. 3⋅98 to 4⋅68) days) and those with a standard dressing
(4⋅1 (3⋅79 to 4⋅32) days).
Three studies described the adverse effects of treatment.
The first study35 stated that NPWT was well tolerated in
all patients, whereas the other two studies (reference 33
and S. Karlakki et al., personal communication) found a
significantly higher risk of blister formation in the iNPWT
group. One study33 was stopped prematurely when 15 of 24
knee incisions treated with a iNPWT dressing developed
skin blisters. The study by Karlakki and colleagues found
that the blisters were minor and most pronounced around
the knees.
Risk of bias across studies
As fewer than ten studies were included in each
meta-analysis, the assessment of publication bias using
a funnel plot is not reported45. The meta-analysis did,
however, include studies favouring both treatments.
Discussion
This systematic review and meta-analysis demonstrated
that iNPWT reduced the rate of wound infection, seroma
formation and wound exudate compared with stan-
dard postoperative dressings in surgical patients at risk of
wound complications. There was no evidence that iNPWT
reduces the risk of other types of wound complication.
However, the diversity in clinical and methodological
aspects implies that the results should be interpreted with
caution, and no absolute or general recommendations can
be made.
Of the ten included studies, seven had wound infection
as a primary or secondary outcome. The RRs found in
individual studies suggested that iNPWT increased the
risk of deep wound infection (reference 33 and B. D.
Crist et al., personal communication). However, this find-
ing was based on a small number of incidents and there-
fore had weak statistical power. A relatively large number
of patients were lost to follow-up in the control groups in
these studies. Thismay have resulted in an underestimation
of the infection rate in the control group. In general, the
included studies were small and underpowered, rendering
a meta-analysis more relevant. The follow-up intervals and
assessment timings were recorded in only two studies (S.
Karlakki et al. and R. Galiano et al., personal communica-
tion), and these differed. Accordingly, small and underpow-
ered studies are a weakness of the present meta-analysis.
Its strength is that, individually, the two largest published
studies35,37 showed significant results favouring iNPWT.
Overall, iNPWT appeared to reduce the risk of wound
infection, even though the quality of evidence was down-
graded to moderate; this means that the true effect is likely
to be close to the estimate of the effect, although there
is a probability of a substantial difference30. The study by
Stannard and co-workers37 included 249 patients with 263
fractures, indicating that some patients had more than one
fracture. Owing to lack of information it was not possible
to adjust the design effect when synthesizing the results.
The true standard error will be slightly smaller, which will
result in a slightly higher weight. Accordingly, the theo-
retical upper limit of 95 per cent c.i. of the pooled results
will increase slightly. However, given that only 5⋅6 per cent
of the patients (14 of 249) had more than one wound, it
is unlikely that the unadjusted RR would affect the pooled
estimate significantly. TheNNT to avoid onewound infec-
tion (25, 95 per cent c.i. 17 to 93) is relatively high consid-
ering the cost of treatment. However, the risk of develop-
ing an infection depends on the type of surgery as well as
patient risk factors. Accordingly, the absolute number of
patients, as well as the clinical importance, should be taken
into consideration when interpreting the NNT.
Wound dehiscence can be caused by excessive tension
on the wound edges, owing to the wound being located
on a highly mobile or tensile area, or to wound infection.
A study20 exploring the biomechanical mechanisms found
that iNPWT reduced lateral tension and shared stress
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concentration at the sutures, which decreased the likeli-
hood of dehiscence and possibly improved the cosmetic
result. Four studies exploring the effect of iNPWT on
wound dehiscence were included in the meta-analysis.
In the largest study, by R. Galiano et al. (personal com-
munication), the patients had bilateral reduction mam-
moplasty and were treated with both iNPWT and a
standard dressing to enable within-patient comparisons.
Furthermore, follow-up intervals and assessment timings
were well recorded. The study favouring standard dressing
was the smallest (81 patients) and also had the highest
number of events in both groups (30 versus 36 per cent)36.
The quality of evidence was downgraded to low, indicating
that confidence in the effect estimate was limited and the
true effect may be substantially different from the esti-
mate of the effect30. Accordingly, more studies are needed
to examine the effect of iNPWT on wound dehiscence.
The three studies34,38,39 that reported on seroma for-
mation were performed by the same research team,
rendering the study designs comparable. Owing to some
risk of bias within the studies, and because all three studies
had a small sample size (19–21 patients), the quality of
evidence was downgraded to moderate. The pooled results
showed a convincing effect of iNPWT on seroma forma-
tion. The NNT to avoid one seroma (3, 95 per cent c.i. 2
to 8) suggested that iNPWT might be cost-effective with
respect to reducing the risk of seroma formation within the
first 10 days after surgery. However, with a mean reduc-
tion of 1⋅97ml (day 5) and 1⋅44ml (day 10), the clinical
relevance is questionable. A larger effect was found in an
animal study21 focusing on the effect of iNPWT treat-
ment on lymph clearance. The authors found that 4 days
of treatment reduced the quantity of haematoma/seroma
by a mean(s.e.m.) of 25(8) g in iNPWT sites compared
with control sites. All three studies included in this review
had a hospital-based follow-up of 10 days, which could be
a weakness. Seroma volume and the duration of seroma
production depend on many factors, including anatomical
site, surgical procedure and the size of the defect. Many
seromas might have decreased by day 10, but the total
seroma production and a possible effect of iNPWT on
this is difficult to assess when the patients have not been
followed to the end of fluid production. Accordingly,
longer follow-up would be preferable.
The effect of iNPWT on wound exudate might be
explained by the known biomechanical mechanisms that
iNPWT applies to the tissue, such as a reduction in
oedema, increased blood flow14,19 and lymph clearance21.
In contrast to the study on wound exudate (S. Karlakki
et al., personal communication), the study that investi-
gated ‘days to dry wounds’33 as a primary outcome found
no effect of iNPWT. However, the two studies differed
in size and type of iNPWT system (traditional33 versus
new device) and the length of application on the incision
(2 days33 versus 7 days).
Despite being RCTs, the studies in this review have
weaknesses. There is some clinical and methodological
heterogeneity as the studies did not assess the same surgical
procedures, nor did they have exactly the same definition of
the chosen outcomes. Three different devices, (PICOTM,
PrevenaTM and VAC®) were used. Owing to differences
in recommendations of duration of treatment, studies with
2–3 days of treatment were included together with studies
with 5–7 days.
Another weakness is the duration of follow-up, which var-
ied from10 days to 1 year. A surgical-site infection is by def-
inition incisional (superficial or deep) or organ/space infec-
tion occurring within 30 days of surgery46. The risk is pro-
longed to 1 year if an implant is left in place46. In addition,
only two studies, by S. Karlakki et al. and R. Galiano et al.
(personal communications), recorded the time intervals
of evaluation and how the outcomes were assessed after
discharge.
With respect to the commercially available NPWT
devices used in the studies, it is a weakness that almost all
included studies were either sponsored or had at least one
consultant of themanufacturer as a co-author. On the other
hand, an advantage of the sponsoredNPWTdevices is that
the results and the recommendations of the studies are eas-
ily applicable to daily clinical decisions. Furthermore, this
review included studies both favouring iNPWT and those
favouring standard dressings.
This systematic review and meta-analysis has demon-
strated that iNPWT reduces the rate of a number of
wound complications compared with standard postopera-
tive dressings. However, more RCTs should be performed.
This is especially important for specific high-risk surgical
patients, such as those with diabetes or obesity. These trials
should be suitably powered and follow international guide-
lines in methodology. The length of follow-up should be
30 days when wound infection is the outcome of interest,
expanded to 1 year if an implant is left in place. An eco-
nomic evaluation should also be performed as part of the
clinical trial.
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